News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
268,282 Results
Type
Article (13932)
Company Profile (102)
Press Release (254248)
Multimedia
Podcasts (51)
Webinars (12)
Section
Business (88146)
Career Advice (465)
Deals (15362)
Drug Delivery (67)
Drug Development (36636)
Employer Resources (49)
FDA (6315)
Job Trends (6211)
News (150398)
Policy (14071)
Tag
Academia (441)
Accelerated approval (4)
Adcomms (6)
Allergies (41)
Alliances (23316)
ALS (42)
Alzheimer's disease (413)
Antibody-drug conjugate (ADC) (54)
Approvals (6373)
Artificial intelligence (136)
Autoimmune disease (10)
Automation (5)
Bankruptcy (150)
Best Places to Work (4370)
BIOSECURE Act (9)
Biosimilars (67)
Biotechnology (40)
Bladder cancer (24)
Brain cancer (19)
Breast cancer (107)
Cancer (825)
Cardiovascular disease (87)
Career advice (410)
Career pathing (12)
CAR-T (30)
CDC (3)
Cell therapy (104)
Cervical cancer (5)
Clinical research (31230)
Collaboration (436)
Compensation (200)
Complete response letters (18)
COVID-19 (765)
CRISPR (28)
C-suite (179)
Cystic fibrosis (45)
Data (917)
Denatured (16)
Depression (16)
Diabetes (96)
Diagnostics (1336)
Digital health (2)
Diversity (2)
Diversity, equity & inclusion (14)
Drug discovery (70)
Drug pricing (80)
Drug shortages (12)
Duchenne muscular dystrophy (48)
Earnings (32561)
Editorial (14)
Employer branding (4)
Employer resources (44)
Events (38016)
Executive appointments (467)
FDA (6912)
Friedreich's ataxia (2)
Frontotemporal dementia (1)
Funding (283)
Gene editing (46)
Generative AI (9)
Gene therapy (115)
GLP-1 (379)
Government (1325)
Grass and pollen (3)
Guidances (77)
Healthcare (3571)
HIV (7)
Huntington's disease (5)
IgA nephropathy (19)
Immunology and inflammation (43)
Immuno-oncology (2)
Indications (19)
Infectious disease (804)
Inflammatory bowel disease (59)
Inflation Reduction Act (7)
Influenza (14)
Intellectual property (63)
Interviews (59)
IPO (5903)
IRA (31)
Job creations (2055)
Job search strategy (373)
Kidney cancer (7)
Labor market (18)
Layoffs (190)
Leadership (5)
Legal (3441)
Liver cancer (20)
Longevity (6)
Lung cancer (111)
Lymphoma (69)
Machine learning (4)
Management (16)
Manufacturing (207)
MASH (40)
Medical device (1288)
Medtech (1290)
Mergers & acquisitions (9728)
Metabolic disorders (308)
Multiple sclerosis (26)
NASH (14)
Neurodegenerative disease (32)
Neuropsychiatric disorders (11)
Neuroscience (642)
NextGen: Class of 2025 (1588)
Non-profit (597)
Now hiring (11)
Obesity (173)
Opinion (129)
Ovarian cancer (27)
Pain (66)
Pancreatic cancer (27)
Parkinson's disease (52)
Partnered (7)
Patents (148)
Patient recruitment (45)
Peanut (12)
People (29199)
Pharmaceutical (64)
Pharmacy benefit managers (14)
Phase I (8128)
Phase II (13201)
Phase III (11867)
Pipeline (664)
Policy (96)
Postmarket research (1402)
Preclinical (3264)
Press Release (25)
Prostate cancer (62)
Psychedelics (9)
Radiopharmaceuticals (125)
Rare diseases (204)
Real estate (2642)
Recruiting (17)
Regulatory (10279)
Reports (14)
Research institute (568)
Resumes & cover letters (55)
Rett syndrome (1)
RNA editing (4)
RSV (9)
Schizophrenia (44)
Series A (53)
Series B (23)
Service/supplier (3)
Sickle cell disease (35)
Special edition (6)
Spinal muscular atrophy (77)
Sponsored (7)
Startups (1638)
State (2)
Stomach cancer (3)
Supply chain (36)
Tariffs (43)
The Weekly (33)
Vaccines (178)
Venture capital (19)
Weight loss (102)
Women's health (10)
Worklife (4)
Date
Today (29)
Last 7 days (138)
Last 30 days (667)
Last 365 days (11166)
2025 (6087)
2024 (12507)
2023 (14247)
2022 (19564)
2021 (20081)
2020 (19034)
2019 (14889)
2018 (11713)
2017 (13892)
2016 (13134)
2015 (15476)
2014 (12419)
2013 (10593)
2012 (11395)
2011 (11924)
2010 (10890)
Location
Africa (314)
Alabama (16)
Alaska (1)
Arizona (61)
Arkansas (3)
Asia (20368)
Australia (2635)
California (2169)
Canada (1089)
China (339)
Colorado (88)
Connecticut (87)
Delaware (77)
Europe (39893)
Florida (422)
Georgia (46)
Hawaii (1)
Idaho (9)
Illinois (246)
India (16)
Indiana (164)
Iowa (1)
Japan (140)
Kansas (62)
Kentucky (16)
Louisiana (2)
Maine (2)
Maryland (311)
Massachusetts (1859)
Michigan (35)
Minnesota (112)
Mississippi (1)
Missouri (24)
Montana (8)
Nebraska (6)
Nevada (12)
New Hampshire (6)
New Jersey (960)
New Mexico (7)
New York (642)
North Carolina (459)
North Dakota (2)
Northern California (898)
Ohio (55)
Oklahoma (4)
Oregon (16)
Pennsylvania (522)
Puerto Rico (9)
Rhode Island (10)
South America (504)
South Carolina (5)
Southern California (917)
Tennessee (42)
Texas (296)
United States (8944)
Utah (45)
Virginia (104)
Washington D.C. (38)
Washington State (143)
West Virginia (1)
Wisconsin (22)
268,282 Results for "eton pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Eton Pharmaceuticals Announces Addition to Russell 2000® and Russell 3000® Indexes
June 27, 2025
·
3 min read
Press Releases
Eton Pharmaceuticals Announces FDA Acceptance of New Drug Application for ET-600 (Desmopressin Oral Solution)
July 8, 2025
·
3 min read
Press Releases
Eton Pharmaceuticals to Participate at Upcoming May 2025 Investor Conferences
May 15, 2025
·
1 min read
Press Releases
Eton Pharmaceuticals Reports First Quarter 2025 Financial Results
May 14, 2025
·
20 min read
Press Releases
Eton Pharmaceuticals Announces U.S. FDA Approval for KHINDIVI™ (hydrocortisone) Oral Solution
May 29, 2025
·
15 min read
Press Releases
Eton Pharmaceuticals Out-Licenses International Rights to Increlex®
April 2, 2025
·
3 min read
Press Releases
Eton Pharmaceuticals Announces Submission of NDA for ET-600 (Desmopressin Oral Solution)
April 28, 2025
·
3 min read
Press Releases
Eton Pharmaceuticals to Report First Quarter 2025 Financial Results on Tuesday, May 13, 2025
May 1, 2025
·
1 min read
Press Releases
Eton Pharmaceuticals Reports Fourth Quarter 2024 Financial Results
March 18, 2025
·
13 min read
Press Releases
CROSSJECT updates on its collaboration with ETON PHARMACEUTICALS, Inc. and the ZENEO® adrenal insufficiency program
March 25, 2025
·
4 min read
1 of 26,829
Next
